Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Breast Cancer Res Treat. 2011 Feb 25;127(1):153–162. doi: 10.1007/s10549-011-1413-6

Table 1.

Dose levels explored

Dose level Number of patients (evaluable) Imatinib oral daily continuously (1st dose: Cycle 1 Day 8) (mg) Docetaxel intravenous days 1, 8, and 15 (mg/m2)
Dose level 1 (Starting Cohort) 4 (3) 600 20
Dose level 2 6 (4) 600 25
Dose level 2a 2 (2) 400 25